Open Access

Erratum to: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts

  • Eva Johanna Kubosch1,
  • Anke Bernstein1,
  • Laura Wolf1,
  • Tobias Fretwurst2,
  • Katja Nelson2 and
  • Hagen Schmal1, 3, 4Email author
BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201617:118

https://doi.org/10.1186/s12891-016-0976-0

Published: 9 March 2016

The original article was published in BMC Musculoskeletal Disorders 2016 17:77

Erratum

After publication of the original article [1], the authors noticed an error in the ‘Methods’ section. Within the ‘Patients’ sub-section, the first item in the list of synthetic or highly processed xenogeneic bone substitutes (SBS) should have been given as Orthoss®, rather than BioOss®. The sentence should therefore have read as follows:

“The following SBS were used: Orthoss® (Geistlich, Wolhusen, Switzerland) in 41.4 %, and at clearly lower percentages, respectively: Norian SRS® (Synthes) (8.6 %), Chronos® (Synthes) (1.7 %), Atlantik® (Argomedical) (2.6 %), Alaska® (Argomedical) (0.9 %), Endobone® (Biomet) (4.3 %), Pyrost® (Stryker) (0.9 %), Nanostim® (Medtronic) (37.1 %), Actifuse® (Baxter) (0.9 %), Tutobone® (Novomedics) (0.9 %) and PerOssal® (Botiss) (0.9 %).”

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Orthopedics and Trauma Surgery, Albert-Ludwigs University Medical Center
(2)
Department of Craniomaxillofacial Surgery, Albert-Ludwigs University Medical Center
(3)
Department of Orthopaedics and Traumatology, Odense University Hospital
(4)
Department of Clinical Research, University of Southern Denmark

Reference

  1. Kubosch EJ, Bernstein A, Wolf L, Fretwurst T, Nelson K, Schmal H. Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highlyprocessed xenogeneic bone grafts. BMC Musc Disord. 2016;17:77.Google Scholar

Copyright

© Kubosch et al. 2016

Advertisement